TP53 and neoplasm: Due to its important tumor suppressor function, most p53-based therapeutic approaches have focused on either exploiting or enhancing residual p53 functionality or on restoring tumor-suppressor activity with mutp53, rather than removing accumulated/aggregated mutp53 [12].